Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Black Diamond Therapeutics I (BDTX)

99 + Investors. Track Smart Money conviction in BDTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — BDTX

Based on 99 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their BDTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
99 hedge funds hold BDTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +14% more funds vs a year ago

fund count last 6Q
+12 new funds entered over the past year (+14% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 48% buying

52 buying56 selling
Last quarter: 56 funds reduced or exited vs 52 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 34 → 21 → 27 → 19. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 26% medium ■ 30% new
43 out of 99 hedge funds have held BDTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +22%, value -31%

Value
-31%
Shares
+22%
Last quarter: funds added +22% more shares while total portfolio value only changed -31%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

17 → 34 → 21 → 27 → 19 new funds/Q
New funds entering each quarter: 34 → 21 → 27 → 19. BDTX is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 61% veterans vs 30% newcomers

■ 61% veterans ■ 10% 1-2yr ■ 30% new
Entry-cohort mix of 104 holders: 63 (61%) are 2+ year veterans, 10 entered 1–2 years ago, and 31 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
30 of 99 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BDTX

In 2026 Q1, 52 hedge funds were net buyers of BDTX (19 opened a new position, 33 added to an existing one), while 56 reduced or exited (33 trimmed, 23 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 32% of total institutional value in BDTX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 99.

Hedge Fund Ownership: BDTX

How many hedge funds hold BDTX — quarterly history vs. share price
Quarterly hedge fund ownership of BDTX vs. share price

Market Analysis: BDTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BDTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Black Diamond Therapeutics I (BDTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BDTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
BDTX
-20.9%
XLV
+3.2%

BDTX outperformed XLV by -24.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
BDTX
-38.7%
XLV
+4.3%

Since the filing became public, BDTX outperformed XLV by -43.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 0 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: BDTX
99 + Investors

Track Smart Money conviction in BDTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 99 103 -3.88%
13F Shares 36M 30M 22.13%
Total Value $50M $73M -31.32%
New Positions 19 27 -8
Increased Positions 31 37 -6
Closed Positions 23 14 +9
Reduced Positions 32 24 +8
Total Calls 3 4 -25.0%
Total Puts 2 3 -33.33%
PUT/CALL Ratio 0.67 0.75 Bullish

Statistics: BDTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

99 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BDTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BDTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 NEA Management Company, LLC 0.54% 4,448,757 $9.5M
2 AWM Investment Company, Inc. 0.12% 525,000 $1.1M
3 Globeflex Capital L P 0.10% 305,276 $650K
4 Round Rock Advisors LLC 0.09% 274,367 $584K
5 nVerses Capital, LLC 0.06% 31,411 $67K
6 WINTON GROUP Ltd 0.04% 538,259 $1.1M
7 Bridgeway Capital Management, LLC 0.03% 723,477 $1.5M
8 683 Capital Management, LLC 0.03% 247,958 $528K
9 Oxford Asset Management LLP 0.02% 23,083 $49K
10 RB Capital Management, LLC 0.02% 35,000 $75K
11 DLK Investment Management, LLC 0.02% 18,200 $39K
12 Graham Capital Management, L.P. 0.01% 170,899 $364K
13 Diametric Capital, LP 0.01% 15,386 $33K
14 Axq Capital, LP 0.01% 23,598 $50K
15 Ritholtz Wealth Management 0.01% 165,333 $352K
16 Beacon Capital Management, LLC 0.01% 15,615 $33K
17 Susquehanna Portfolio Strategies, LLC 0.01% 173,647 $370K
18 Catalyst Funds Management Pty Ltd 0.01% 15,200 $32K
19 Renaissance Technologies LLC 0.01% 1,643,747 $3.5M
20 NINE MASTS CAPITAL Ltd 0.01% 17,806 $38K
21 Connor, Clark & Lunn Investment Management Ltd. 0.01% 1,058,397 $2.3M
22 Two Sigma Securities, LLC 0.00% 16,663 $35K
23 Empowered Funds, LLC 0.00% 230,177 $490K
24 Bailard, INC. 0.00% 51,500 $110K
25 Prelude Capital Management, LLC 0.00% 13,895 $30K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Black Diamond Therapeutics I (BDTX)

What does the Smart Money Trend signal show for BDTX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their BDTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BDTX?

More sellers than buyers — 48% buying: Last quarter: 56 funds reduced or exited vs 52 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for BDTX holders?

Strong quality — 32% AUM from major funds: 30 of 99 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held BDTX?

43% of holders stayed for 2+ years: 43 out of 99 hedge funds have held BDTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Black Diamond Therapeutics I (BDTX) following the 2026 Q1 hedge fund 13F filings?

As of today, BDTX has moved -38.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +4.3% for the XLV sector ETF — an outperformance of -43.0%. Since the quarter end (March 31, 2026), BDTX has gained -20.9% vs +3.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →